Radiation Oncologists’ Approach to Internal Mammary Lymph Node Radiotherapy in Breast Cancer: The Turkish Society for Radiation Oncology Breast Cancer Study Group (TROD 06-005 Survey Study)

References

• PoortmansPM, ColletteS, KirkoveC, et al.; EORTC Radiation Oncology and Breast Cancer Groups. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med. 2015;373(4):317–327. PMID: 26200978. doi:10.1056/NEJMoa141536926200978
   PubMed Web of Science ®Google Scholar
• WhelanTJ, OlivottoIA, ParulekarWR, et al.; MA.20 Study Investigators. Regional nodal irradiation in early-stage breast cancer. N Engl J Med. 2015;373(4):307–316. doi:10.1056/NEJMoa1415340.26200977
   PubMed Web of Science ®Google Scholar
• ShahC, BadiyanS, BerryS, et al. Cardiac dose sparing and avoidance techniques in breast cancer radiotherapy. Radiother Oncol. 2014;112(1):9–16. PMID: 24813095. doi:10.1016/j.radonc.2014.04.00924813095
   PubMed Web of Science ®Google Scholar
• MeattiniI, GuenziM, FozzaA, et al. Overview on cardiac, pulmonary and cutaneous toxicity in patients treated with adjuvant radiotherapy for breast cancer. Breast Cancer. 2017;24(1):52–62. PMID: 27025498. doi:10.1007/s12282-016-0694-3.27025498
   PubMed Web of Science ®Google Scholar
• ThorsenLB, ThomsenMS, BergM; et al., Danish Breast Cancer Cooperative Group Radiotherapy committee. CT-planned internal mammary node radiotherapy in the DBCG-IMN study: benefit versus potentially harmful effects. Acta Oncol. 2014;53:1027–1034. doi:10.3109/0284186X.2014.92557924957557
   PubMed Web of Science ®Google Scholar
• ThorsenLB, OffersenBV, DanøH, et al. DBCG-IMN: a population-based cohort study on the effect of internal mammary node irradiation in early node-positive breast cancer. J Clin Oncol. 2016;34(4):314–320. doi:10.1200/JCO.2015.63.645626598752
   PubMed Web of Science ®Google Scholar
• BormKJ, KesselK, DeveckaM, et al. variability in lymph node irradiation in patients with breast cancer-results from a multi-center survey in German-speaking countries. Strahlenther Onkol. 2020;196(1):15–22. doi:10.1007/s00066-019-01537-331722060
   PubMed Web of Science ®Google Scholar
• RoumeliotisM, LongK, PhanT, GrahamD, QuirkS. Including internal mammary lymph nodes in radiation therapy for synchronous bilateral breast cancer: an international survey of treatment technique and clinical priorities. Breast Cancer Res Treat. 2018;171(2):471–475. doi:10.1007/s10549-018-4848-129869775
   PubMed Web of Science ®Google Scholar
• TaghianA, JagsiR, MakrisA, et al. Results of a survey regarding irradiation of internal mammary chain in patients with breast cancer: practice is culture driven rather than evidence based. Int J Radiat Oncol Biol Phys. 2004;60(3):706–714. doi:10.1016/j.ijrobp.2004.04.02715465186
   PubMed Web of Science ®Google Scholar
• ClavelS, RoyI, CarrierJF, RousseauP, FortinMA. Adjuvant regional irradiation after breast-conserving therapy for early stage breast cancer: a survey of canadian radiation oncologists. Clin Oncol (R Coll Radiol). 2010;22(1):39–45. doi:10.1016/j.clon.2009.09.02619945833
   PubMed Web of Science ®Google Scholar
• PoortmansPM, WeltensC, FortpiedC, et al. Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomized, phase 3 trial [published correction appears in Lancet Oncol. 2021 Jan;22(1):e5]. Lancet Oncol. 2020;21(12):1602–1610. doi:10.1016/S1470-2045(20)30472-133152277
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomized trials. Lancet. 2011;378:1707–16. 34. doi:10.1016/S0140-6736(11)61629-222019144
   PubMed Web of Science ®Google Scholar
• GradisharWJ, MoranMS, AbrahamJ, et al. NCCN guidelines® insights: breast cancer, version 4.2021. J Natl Compr Canc Netw. 2021;19(5):484–493. doi:10.6004/jnccn.2021.002334030128
   PubMed Web of Science ®Google Scholar
• DumaMN, MünchS, OechsnerM, et al. Heart-sparing radiotherapy in patients with breast cancer: what are the techniques used in the clinical routine? A pattern of practice survey in the German-speaking countries. Med Dosim. 2017;42(3):197–202. doi:10.1016/j.meddos.2017.03.00228502653
   PubMed Web of Science ®Google Scholar
• RutterCE, ChagparAB, EvansSB. Breast cancer laterality does not influence survival in a large modern cohort: implications for radiation-related cardiac mortality. Int J Radiat Oncol Biol Phys. 2014;90(2):329–334. doi:10.1016/j.ijrobp.2014.06.03025304793
   PubMed Web of Science ®Google Scholar
• BoeroIJ, ParavatiAJ, TriplettDP, et al. Modern radiation therapy and cardiac outcomes in breast cancer. Int J Radiat Oncol Biol Phys. 2016;94(4):700–708. doi:10.1016/j.ijrobp.2015.12.01826972642
   PubMed Web of Science ®Google Scholar
• DessRT, LissAL, GriffithKA, et al. Ischemic cardiac events following treatment of the internal mammary nodal region using contemporary radiation planning techniques. Int J Radiat Oncol Biol Phys. 2017;99(5):1146–1153. doi:10.1016/j.ijrobp.2017.06.245928864405
   PubMed Web of Science ®Google Scholar
• RangerA, DunlopA, HutchinsonK, et al. A dosimetric comparison of breast radiotherapy techniques to treat locoregional lymph nodes including the internal mammary chain. Clin Oncol (R Coll Radiol). 2018;30(6):346–353. doi:10.1016/j.clon.2018.01.01729483041
   PubMed Web of Science ®Google Scholar
• MamounasEP, WhiteJR, BandosH, et al. NSABP B-51/ RTOG 1304: randomized phase III clinical trial evaluating the role of postmastectomy chest wall and regional nodal XRT (CWRNRT) and post-lumpectomy RNRT in patients with documented positive axillary (Ax) nodes before neoadjuvant chemotherapy (NC) who convert to pathologically negative Ax nodes after NC. JCO. 2014;32(15 supp):tps1141.
   Google Scholar
• GregucciF, FozzaA, FaliveneS, et al.; Italian Society of Radiotherapy and Clinical Oncology (AIRO) Breast Group. Present clinical practice of breast cancer radiotherapy in Italy: a nationwide survey by the Italian Society of Radiotherapy and Clinical Oncology (AIRO) Breast Group. Radiol Med. 2020;125(7):674–682. doi:10.1007/s11547-020-01147-532078120
   PubMed Web of Science ®Google Scholar
• FozzaA, Giaj-LevraN, De RoseF, et al. Lymph nodal radiotherapy in breast cancer: what are the unresolved issues?Expert Rev Anticancer Ther. 2021;21(8):827–840. doi:10.1080/14737140.2021.191739033852379
   PubMed Web of Science ®Google Scholar
• WangSL, FangH, SongYW, et al. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial. Lancet Oncol. 2019;20(3):352–360. doi:10.1016/S1470-2045(18)30813-130711522
   PubMed Web of Science ®Google Scholar